North Carolina Central University has teamed with the pharmaceutical manufacturer ViiV to lower the impact of HIV in African American and other minority populations.
The initiative will develop implementation science capacity at NCCU and train NCCU students in implementation science research, which integrates new research findings into development of health policy and clinical practice.